2011年5月31日下午3：00，美国Kentucky大学Alan Daugherty 教授及Hong Lu教授赴北京安贞医院开展学术讲座。Alan Daugherty教授是美国肯德基大学心血管研究中心主任，美国心脏协会（AHA）动脉硬化血栓形成血管生理分会（ATVB）主席，在动脉硬化和动脉瘤的研究中具有很高的造诣。讲座在心外科五层会议室举行。医院部分工作人员和研究生现场听取了报告。
　　 会议由首都医科大学特聘教授、北京市心肺血管疾病研究所副所长杜杰教授主持，Alan Daugherty教授讲座题目：Angiotensin II as a pivotal mediator of aortic aneurysms-evidence from the bench to bedside，其助手Hong Lu讲座题目：Renin Angiotensin System and Atherosclerosis。现场观众对两位教授丰硕的研究成果报以热烈的掌声，讨论非常热烈，大家对血管紧张素II在腹主动脉瘤和动脉粥样硬化中的作用有了新的认识，对该动物模型有了更深层次的理解。本次会议由首都医科大学附属北京安贞医院、北京市心肺血管疾病研究所、省部共建教育部心血管重塑相关疾病重点实验室和首都医科大学心血管转化医学研究中心共同举办。

                                                                                                           撰稿人:秦彦文
 

专家简介：
Alan Daugherty, Ph.D., D.Sc.
professor of medicine and professor of physiology, University of Kentucky，
 College of Medicine Senior Associate Dean for Research
Gill Foundation Chair in Preventive Cardiology
Professor of Medicine and Physiology
Associate Chair of Medicine for Physician Scientist Training
Director, Saha Cardiovascular Research Center
Immediate Past Chair, ATVB Council of AHA
American Heart Association 2009 Science Advocate of the Year
Associate editor of the journal of “Circulation Research”（IF：9.989）
 Editor-in-chief of the journal of “Arteriosclerosis, Thrombosis, and Vascular Biology”（IF：7.235）
Research Interests:
Daugherty’s research interests center around cardiovascular disease, in particular, processes in the development of lesions in atherosclerosis select hardening of the arteries) and abdominal aortic aneurysms select AAA union all which is an abnormal ballooning of the major artery from the heart.
Hong Lu
Research assistant professor, Internal Medicine Department, University of Kentucky, Lexington, KY
American Heart Association
American Society of Investigative Pathology
Research Interests:
Area of research focuses on how the overactivation of the renin-angiotensin system plays an important role in the development of atherosclerosis and aneurysmal formation. Specific interest is to define the mechanisms by which the renin-angiotensin system contributes to these two vascular pathologies using specific pharmacological tools or genetic disruption approaches. Studies are performed using mouse models and cell culture system.